| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
International Agency for Research on Cancer, 69372 Lyon, France [R. K., A. L.]; Department of Public Health and Clinical Medicine/Nutritional Research, Umeå University Hospital, Sweden [A. L.]; and Department of Food Science and Nutrition, College of Agricultural, Food and Environmental Sciences, College of Human Ecology, St. Paul, Minnesota 55108 [M. S. K.]
Endometrial cancer is a disease of the affluent, developed world, where epidemiological studies have shown that 
40% of its incidence can be attributed to excess body weight. An additional proportion may be because of lack of physical activity. Alterations in endogenous hormone metabolism may provide the main links between endometrial cancer risk, and excess body weight and physical inactivity. Epidemiological studies have shown increased endometrial cancer risks among pre- and postmenopausal women who have elevated plasma androstenedione and testosterone, and among postmenopausal women who have increased levels of estrone and estradiol. Furthermore, there is evidence that chronic hyperinsulinemia is a risk factor.
These relationships can all be interpreted in the light of the "unopposed estrogen" hypothesis, which proposes that endometrial cancer may develop as a result of the mitogenic effects of estrogens, when these are insufficiently counterbalanced by progesterone. In our overall synthesis, we conclude that development of ovarian hyperandrogenism may be a central mechanism relating nutritional lifestyle factors to endometrial cancer risk. In premenopausal women, ovarian hyperandrogenism likely increases risk by inducing chronic anovulation and progesterone deficiency. After the menopause, when progesterone synthesis has ceased altogether, excess weight may continue increasing risk through elevated plasma levels of androgen precursors, increasing estrogen levels through the aromatization of the androgens in adipose tissue. The ovarian androgen excess may be because of an interaction between obesity-related, chronic hyperinsulinemia with genetic factors predisposing to the development of ovarian hyperandrogenism.
This article has been cited by other articles:
|
|
 |
|
  N. E Allen, T. J Key, L. Dossus, S. Rinaldi, A. Cust, A. Lukanova, P. H Peeters, N C. Onland-Moret, P. H Lahmann, F. Berrino, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, June 1, 2008; 15(2): 485 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gnagnarella, S. Gandini, C. La Vecchia, and P. Maisonneuve Glycemic index, glycemic load, and cancer risk: a meta-analysis Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1793 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, J. E. Manson, J. Li, T. G. Harris, T. E. Rohan, X. Xue, G. Y.F. Ho, et al. A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer Cancer Res., April 1, 2008; 68(7): 2507 - 2513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rapp, J. Klenk, H. Ulmer, H. Concin, G. Diem, W. Oberaigner, and J. Schroeder Weight change and cancer risk in a cohort of more than 65 000 adults in Austria Ann. Onc., April 1, 2008; 19(4): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Deming, W. Zheng, W.-H. Xu, Q. Cai, Z. Ruan, Y.-B. Xiang, and X.-O. Shu UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. McCullough, A. V. Patel, R. Patel, C. Rodriguez, H. S. Feigelson, E. V. Bandera, T. Gansler, M. J. Thun, and E. E. Calle Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V Bandera, L. H Kushi, D. F Moore, D. M Gifkins, and M. L McCullough Association between dietary fiber and endometrial cancer: a dose-response meta-analysis Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1730 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sedjo, T. Byers, E. Barrera Jr., C. Cohen, E. T. H. Fontham, L. A. Newman, C. D. Runowicz, A. G. Thorson, M. J. Thun, E. Ward, et al. A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015 CA Cancer J Clin, November 1, 2007; 57(6): 326 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Viswanathan, S. E. Hankinson, and E. S. Schernhammer Night Shift Work and the Risk of Endometrial Cancer Cancer Res., November 1, 2007; 67(21): 10618 - 10622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Cust, N. Slimani, R. Kaaks, M. van Bakel, C. Biessy, P. Ferrari, M. Laville, A. Tjonneland, A. Olsen, K. Overvad, et al. Dietary Carbohydrates, Glycemic Index, Glycemic Load, and Endometrial Cancer Risk within the European Prospective Investigation into Cancer and Nutrition Cohort Am. J. Epidemiol., October 15, 2007; 166(8): 912 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E Cust, R. Kaaks, C. Friedenreich, F. Bonnet, M. Laville, A. Tjonneland, A. Olsen, K. Overvad, M. U. Jakobsen, V. Chajes, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, September 1, 2007; 14(3): 755 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Micheli, E. Meneghini, G. Secreto, F. Berrino, E. Venturelli, A. Cavalleri, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, et al. Plasma Testosterone and Prognosis of Postmenopausal Breast Cancer Patients J. Clin. Oncol., July 1, 2007; 25(19): 2685 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Jones, E. J. Folkerd, D. A. Doody, J. Iqbal, M. Dowsett, A. Ashworth, and A. J. Swerdlow Effect of Delays in Processing Blood Samples on Measured Endogenous Plasma Sex Hormone Levels in Women Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1136 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Tao, Q. Cai, Z.-F. Zhang, W.-H. Xu, N. Kataoka, W. Wen, Y.-B. Xiang, W. Zheng, and X. O. Shu Polymorphisms in the CYP19A1 (Aromatase) Gene and Endometrial Cancer Risk in Chinese Women Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Nielsen, K. Strandberg-Larsen, M. Gronbaek, T. S. Kristensen, P. Schnohr, and Z.-F. Zhang Self-Reported Stress and Risk of Endometrial Cancer: A Prospective Cohort Study Psychosom Med, May 1, 2007; 69(4): 383 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Voskuil, E. M. Monninkhof, S. G. Elias, F. A. Vlems, F. E. van Leeuwen, and Task Force Physical Activity and Cancer Physical Activity and Endometrial Cancer Risk, a Systematic Review of Current Evidence Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 639 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Saxena, D. Sharma, X. Ding, S. Lin, F. Marra, D. Merlin, and F. A. Anania Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma Cells Cancer Res., March 15, 2007; 67(6): 2497 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Jordan, A. C. Green, D. C. Whiteman, P. M. Webb, for the Australian Ovarian Cancer Study Group, and the Australian Cancer Study (Ovarian Cancer) Risk Factors for Benign Serous and Mucinous Epithelial Ovarian Tumors Obstet. Gynecol., March 1, 2007; 109(3): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Legro A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome JAMA, February 7, 2007; 297(5): 509 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Olson, E. V. Bandera, and I. Orlow Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Cust, R. Kaaks, C. Friedenreich, F. Bonnet, M. Laville, A. Lukanova, S. Rinaldi, L. Dossus, N. Slimani, E. Lundin, et al. Plasma Adiponectin Levels and Endometrial Cancer Risk in Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Campbell and A. McTiernan Exercise and Biomarkers for Cancer Prevention Studies J. Nutr., January 1, 2007; 137(1): 161S - 169S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mahabir, D. J. Baer, L. L. Johnson, T. J. Hartman, J. F. Dorgan, W. S. Campbell, B. A. Clevidence, and P. R. Taylor Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2502 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Friberg, C. S. Mantzoros, and A. Wolk Physical Activity and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2136 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cowey and R. W. Hardy The Metabolic Syndrome: A High-Risk State for Cancer? Am. J. Pathol., November 1, 2006; 169(5): 1505 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Taylor, M. A. Powell, R. K. Gibb, J. S. Rader, P. C. Huettner, S. N. Thibodeau, D. G. Mutch, and P. J. Goodfellow MLH3 Mutation in Endometrial Cancer. Cancer Res., August 1, 2006; 66(15): 7502 - 7508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dossus, F. Canzian, R. Kaaks, A. Boumertit, and E. Weiderpass No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1415 - 1416. [Full Text] [PDF]
|
|
|
|
|
|
D Sharma, N K Saxena, P M Vertino, and F A Anania Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer, June 1, 2006; 13(2): 629 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Missmer, D. Spiegelman, E. R. Bertone-Johnson, R. L. Barbieri, M. N. Pollak, and S. E. Hankinson Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 972 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, H. Shen, P. Xiao, D.-H. Xiong, T.-L. Yang, Y.-F. Guo, J.-R. Long, R. R. Recker, and H.-W. Deng Genomewide Linkage Scan for Quantitative Trait Loci Underlying Variation in Age at Menarche J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1009 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim and B. M Popkin Commentary: Understanding the epidemiology of overweight and obesity--a real global public health concern Int. J. Epidemiol., February 1, 2006; 35(1): 60 - 67. [Full Text] [PDF]
|
|
|
|
|
|
W. H. Xu, Y. B. Xiang, W. Zheng, X. Zhang, Z. X. Ruan, J. R. Cheng, Y.-T. Gao, and X.-O. Shu Weight history and risk of endometrial cancer among Chinese women Int. J. Epidemiol., February 1, 2006; 35(1): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Trentham-Dietz, H. Nichols, J. Hampton, and P. Newcomb Weight change and risk of endometrial cancer Int. J. Epidemiol., February 1, 2006; 35(1): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Thibaudeau, J. Lepine, J. Tojcic, Y. Duguay, G. Pelletier, M. Plante, J. Brisson, B. Tetu, S. Jacob, L. Perusse, et al. Characterization of Common UGT1A8, UGT1A9, and UGT2B7 Variants with Different Capacities to Inactivate Mutagenic 4-Hydroxylated Metabolites of Estradiol and Estrone Cancer Res., January 1, 2006; 66(1): 125 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Matthews, W. H. Xu, W. Zheng, Y. T. Gao, Z. X. Ruan, J. R. Cheng, Y. B. Xiang, and X. O. Shu Physical Activity and Risk of Endometrial Cancer: A Report from the Shanghai Endometrial Cancer Study Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Schouten, R. A. Goldbohm, and P. A. van den Brandt Anthropometry, Physical Activity, and Endometrial Cancer Risk: Results From The Netherlands Cohort Study J Natl Cancer Inst, November 3, 2004; 96(21): 1635 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Aebi Endometrial cancer: a frequent orphan disease Ann. Onc., August 1, 2004; 15(8): 1149 - 1150. [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Mayer, P. J. Devine, C. A. Dyer, and P. B. Hoyer The Follicle-Deplete Mouse Ovary Produces Androgen Biol Reprod, July 1, 2004; 71(1): 130 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Lacey Jr., N. Potischman, M. P. Madigan, M. L. Berman, R. Mortel, L. B. Twiggs, R. J. Barrett, G. D. Wilbanks, J. R. Lurain, C.-M. Fillmore, et al. Insulin-Like Growth Factors, Insulin-Like Growth Factor-Binding Proteins, and Endometrial Cancer in Postmenopausal Women: Results from a U.S. Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dal Maso, L. S. A. Augustin, A. Karalis, R. Talamini, S. Franceschi, D. Trichopoulos, C. S. Mantzoros, and C. La Vecchia Circulating Adiponectin and Endometrial Cancer Risk J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1160 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Duguay, M. McGrath, J. Lepine, J.-F. Gagne, S. E. Hankinson, G. A. Colditz, D. J. Hunter, M. Plante, B. Tetu, A. Belanger, et al. The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk Cancer Res., February 1, 2004; 64(3): 1202 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Endogenous Hormones Breast Cancer Collaborative Gr Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women J Natl Cancer Inst, August 20, 2003; 95(16): 1218 - 1226. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
